NorthStar Anesthesia Acquires Continental Anesthesia, Expands Presence in Midwest

News provided by

Feb 03, 2016, 06:30 ET

DALLAS, Feb. 3, 2016 /PRNewswire/ -- NorthStar Anesthesia, one of the country's leading anesthesia care companies, announced today that it has acquired Continental Anesthesia, the largest multi-system anesthesia provider in the Chicago area with 17 facilities.

With this combination, NorthStar expands its footprint in Illinois where it currently serves two facilities and increases its team of anesthesiologists and CRNAs to 1,700 providers across the country caring for patients at more than 180 facilities in 20 states. "We are excited about the collaboration with Continental Anesthesia," said NorthStar CEO Chris Riopelle. "Like us, Continental Anesthesia has experience serving multi-facility systems and is dedicated to maintaining the highest quality of care for our patients, as well as the highest level of service to our surgeons and hospital partners."

Antonio Abrego, M.D., President of Continental, added, "Both organizations are committed to the highest quality of patient care and customizing partnerships based on the hospital or ASC's unique needs. That collaboration along with the experience the NorthStar leadership and their caregiver teams bring, are why we are very excited about joining what we believe will become the greatest anesthesia care community in the country."

About NorthStar Anesthesia
NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a CRNA. NorthStar partners with hospitals and ASCs to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high quality while measurably improving operating room performance. That same approach attracted a majority investment from TPG Growth in 2013 and established NorthStar as one of the most successful and fastest growing anesthesia care companies in America. For more information, visit www.northstaranesthesia.com

About TPG Growth
TPG Growth is the middle market and growth equity investment platform of TPG, the global private investment firm. With over $7 billion under management, TPG Growth targets investments in a broad range of industries and geographies. TPG Growth has the deep sector knowledge, operational resources and global experience to drive value creation and help companies reach their full potential. The firm is backed by the resources of TPG, which has approximately $75 billion of assets under management. TPG has a long history of investments in healthcare including Par Pharmaceutical Companies, Biomet, Evolent Health, IASIS Healthcare, Healthscope Limited, Sutures India Pvt Ltd, Surgical Care Affiliates, IMS Health, Go Health, Biomet, Envision Pharmaceutical, Quintiles Transnational, Oxford Health Plans and IMDSoft, among others. TPG Growth has offices in the United States, China, India, Brazil, Turkey, London and Singapore. For more information visit www.tpggrowth.com.